Product Portfolio

Cx Products

The clinically-proven consumer healthcare (Cx) product portfolio was added in 2014 through the acquisition of Rottapharm. Cx products, which can be prescribed or recommended by physicians and pharmacists, are backed by clinical data, which strengthens their credibility and reputation with healthcare professionals.

Meda considers Cx products to be less susceptible to the pricing pressures that affect Rx-products as a result of reference pricing, financial pressure on national health systems and the increased competitiveness of generics.

Key Cx Products


Dona (glucosamine sulfate) is an osteoarthritis treatment drug that acts through the modulation of cytokines, mediators of the biological genesis of the arthritis process, resulting, among other things, in the stimulation of cartilage metabolism, joint protection and a reduction in pain over time, as well as support for joint mobility. The brand name family of Dona includes Viatril, Arthril, DONArot, Artofort, Xicil and Osaflexan. Two long-term clinical studies have shown that Dona is able to delay the progression of knee osteoarthritis and a 6-months study performed according to the EMA rules assessed its role as a symptomatic slow-acting drug for osteoarthritis (SYSADOA). It has been suggested as a first line treatment and basic therapy for the management of knee osteoarthritis by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).


Saugella is a full-range line for daily intimate hygiene. The Saugella range of products target all ages and different hygiene requirements. The Saugella product family includes liquid cleansers, cleansing wipes, gels, creams, and sanitary towels. The Saugella products contain natural extracts with specific properties protecting and respecting the vaginal ecosystem, thereby helping prevent diseases. They are promoted to doctors in obstetrics and gynecology (OB/GYN).



Legalon is used for the treatment of diseases in the liver, especially liver steatosis, for the supportive therapy of chronic inflammatory liver diseases and liver cirrhosis. Legalon is a natural medicine based on milk thistle containing silymarin with its major active ingredient silibinin, which makes up 55% of the mixture. The particular selection of plants and the method of extraction make it unique. The family of Legalon products includes Legalon E, Legasil, Legalon Protect, Legalon Forte, Legalon 70 and Legalon 140. The substance Legalon is classified as a drug.


ArmoLIPID is a line of natural products classified as nutraceuticals and used for dyslipidemia. ArmoLIPID and ArmoLIPID Plus are clinically tested and used when cholesterol and triglyceride levels are high. The formulation ArmoLIPID Prev can also be used when the dyslipidemia is associated with high blood pressure. All these products are well documented and recommended by doctors.


Reparil is used for the treatment of traumatic injuries, edema and venous diseases. Reparil is clinically proven to rapidly relieve pain due to its anti-inflammatory effect. The natural extract inside contributes to reduce edema, a condition often present during trauma and in venous diseases. The family of Reparil products includes various brands such as Reparil Gel, Feparil and Venoparil for topical treatment and also an oral form (Reparil dragees).


GO-ON is a product based on hyaluronic acid injected intra-articularly, used for the treatment of osteoarthritis of the knee and other joints such as shoulder, hand and hip. It is classed as a medical device. The hyaluronic acid is derived from a biosynthetic source and the highly standardized purification process guarantees absence of immunogenic reactions and avian virus contamination. GO-ON does not contain any animal protein or exogenous DNA.

This website is intended for people seeking information on Meda AB's Global operations.
We also have national marketing sites. Links to these are under Meda Worldwide at the top of the page.